Renal Cell Carcinoma Clinical Trials

768 clinical trials for Renal Cell Carcinoma across international registries, including 136 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma — RECRUITING · PHASE1
• Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders — RECRUITING
• GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours — RECRUITING · PHASE1
• A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC) — RECRUITING · PHASE1
• Identification and Description of Patients With High-risk Non Metastatic RCC — RECRUITING
• Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer — RECRUITING · PHASE3
• Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors — RECRUITING · PHASE1
• IDOV-Immune for Advanced Solid Tumors — RECRUITING · PHASE1
• PET/MR for Characterization of Renal Masses (RMs) — RECRUITING
• Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma — RECRUITING · PHASE1
• A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033) — RECRUITING · PHASE3
• A Phase 1 Study of the Safety and Tolerability of CTX-10726 — RECRUITING · PHASE1
• Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer — RECRUITING · PHASE2
• The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas — RECRUITING · PHASE2
• Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) — RECRUITING · PHASE1
• A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• Use of Tracking Devices to Locate Abnormalities During Invasive Procedures — RECRUITING · NA
• DESTINY-PANTUMOUR04 — RECRUITING
• Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell — RECRUITING · PHASE1
• Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis — RECRUITING · PHASE1
• Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03) — RECRUITING · PHASE1
• Study of DCC-2812 in Participants With Advanced Genitourinary Cancers — RECRUITING · PHASE1
• Registry Platform Urologic Cancer — RECRUITING
• Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma — RECRUITING · PHASE4
• A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• To Evaluate the Safety and Tolerability of Anti-Human CD70 T-Cell Injection in Subjects With Advanced/Metastatic Renal Cancer — RECRUITING · PHASE1
• A Study of IBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell Carcinoma — RECRUITING · PHASE2
• Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER) — RECRUITING · NA
• Radical Nephrectomy With vs Without Template Lymph Node Dissection in High-Risk Renal Cell Carcinoma (T-LND RCC) — RECRUITING · NA
• A Phase 1b/2 Study of Immune and Targeted Combination Therapies in Participants with RCC (KEYMAKER-U03): Substudy 03A in First Line Metastatic Participants — RECRUITING · PHASE2
• Study on MRD Prediction of Efficacy of Toripalimab in the Treatment of High-risk Recurrent Renal Carcinoma — RECRUITING
• Investigation of Lymph Node Biology in Kidney Cancer — RECRUITING · NA
• Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program — RECRUITING · PHASE2
• KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors — RECRUITING · PHASE1
• Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma — RECRUITING
• Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing — RECRUITING
• Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma — RECRUITING · PHASE2
• A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products — RECRUITING
• Drug Screening Using Novel IMD in Renal Cell Carcinoma — RECRUITING · PHASE1
• A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors — RECRUITING · PHASE1
• Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment — RECRUITING · PHASE2
• Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy — RECRUITING · NA
• Assessment of Quality of Life and Outcomes in Patients With Primary Renal Cell Carcinoma Treated With SBRT — RECRUITING · NA
• Patient Preference for Subcutaneous vs. Intravenous Immune Therapy — RECRUITING · PHASE2
• Validation of RCC Predicting Model With Emulated-target Trial — RECRUITING
• A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy — RECRUITING · PHASE1
• Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma — RECRUITING · PHASE1
• Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus — RECRUITING · PHASE2
• A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases — RECRUITING · PHASE2
• CBCT Guided Markerless SBRT for Renal Cell Cancer — RECRUITING · NA

Refine this search